Hydroxychloroquine retinopathy.
Yusuf IH, Sharma S, Luqmani R, Downes SM.
Eye (Lond). 2017 Jun;31(6):828-845. doi: 10.1038/eye.2016.298. Epub 2017 Mar 10.
Tamoxifen retinopathy: A comprehensive review.
Tenney S, Oboh-Weilke A, Wagner D, Chen MY.
Surv Ophthalmol. 2024 Jan-Feb;69(1):42-50. doi: 10.1016/j.survophthal.2023.07.003. Epub 2023 Jul 22.
Accelerated hydroxychloroquine toxic retinopathy.
Mohapatra A, Gupta P, Ratra D.
Doc Ophthalmol. 2024 Feb;148(1):37-45. doi: 10.1007/s10633-023-09950-x. Epub 2023 Oct 3.
The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.
Browning DJ.
Am J Ophthalmol. 2016 Jun;166:ix-xi. doi: 10.1016/j.ajo.2016.03.044. Epub 2016 Apr 28.
Electroretinograms.
Creel DJ.
Handb Clin Neurol. 2019;160:481-493. doi: 10.1016/B978-0-444-64032-1.00032-1.
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF; American Academy of Ophthalmology.
Ophthalmology. 2016 Jun;123(6):1386-94. doi: 10.1016/j.ophtha.2016.01.058. Epub 2016 Mar 16.
Hydroxychloroquine-related retinal toxicity.
Ding HJ, Denniston AK, Rao VK, Gordon C.
Rheumatology (Oxford). 2016 Jun;55(6):957-67. doi: 10.1093/rheumatology/kev357. Epub 2015 Oct 1.
Arginase in retinopathy.
Narayanan SP, Rojas M, Suwanpradid J, Toque HA, Caldwell RW, Caldwell RB.
Prog Retin Eye Res. 2013 Sep;36:260-80. doi: 10.1016/j.preteyeres.2013.06.002. Epub 2013 Jul 3.
[Antimalarial drug retinopathy].
Guiot A, Couturier M, Tebib JG, Abouaf L, Coury F.
Rev Med Interne. 2018 May;39(5):364-368. doi: 10.1016/j.revmed.2018.02.013. Epub 2018 Feb 26.
[Exogenously induced retinopathies].
Kellner U, Kellner S, Weinitz S, Farmand G.
Klin Monbl Augenheilkd. 2022 Dec;239(12):1493-1511. doi: 10.1055/a-1961-8166. Epub 2022 Nov 17.
